Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Cypher sirolimus-eluting stent: Pivotal

Additional results from the previously reported international RAVEL study in 238 patients showed the mean in-stent late luminal

Read the full 189 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE